Calcium antagonists show no increased mortality after adjustments for patient differences in Israeli study.
Executive Summary
CALCIUM ANTAGONISTS DO NOT SHOW INCREASED MORTALITY AFTER ADJUSTMENTS for differences between patients receiving calcium channel blockers and those not taking the drugs in an Israeli observational study published in the July issue of the Journal of the American College of Cardiology. "The current analysis does not support the claim that calcium antagonist therapy in patients with coronary artery disease, whether myocardial infarction survivors or others, harbors an increased risk of mortality," state the authors Shimon Braun, MD, et al., Tel Aviv Medical Center.